Working… Menu

Safety and Efficacy of Maraviroc and/or Favipiravir With Standard Therapy in Severe COVID-19 Adults (COMVIVIR)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details. Identifier: NCT04475991
Recruitment Status : Not yet recruiting
First Posted : July 17, 2020
Last Update Posted : April 9, 2021
CCINSHAE. Secretaría de Salud. México
Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran
Centro de Investigación en. Enfermedades Infecciosas, Mexico
Information provided by (Responsible Party):
María Luisa Hernández-Medel, Hospital General de México Dr. Eduardo Liceaga

No Study Results Posted on for this Study
Recruitment Status : Not yet recruiting
Estimated Primary Completion Date : July 2021
Estimated Study Completion Date : September 2021